Lytix Biopharma AS

Lytix Biopharma AS discloses dealings in Lytix Biopharma ASA to Oslo Børs. We count 3 filings; the first trade dates from 26 August 2022 and the latest from 1 September 2025.

Purchases make up the whole of the open-market record (1 purchase, €10k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 option exercises.

On 1 September 2025 came the latest disclosure, an option exercise in Lytix Biopharma ASA. The clock since the last published purchase (26 August 2022) now reads 1,514 days. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.